A detailed history of Novo Holdings transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Novo Holdings holds 358,626 shares of BPMC stock, worth $38.7 Million. This represents 2.76% of its overall portfolio holdings.

Number of Shares
358,626
Previous 359,126 0.14%
Holding current value
$38.7 Million
Previous $33.1 Million 2.7%
% of portfolio
2.76%
Previous 2.78%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$73.17 - $99.79 $36,585 - $49,895
-500 Reduced 0.14%
358,626 $34 Million
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $7.29 Million - $15.4 Million
-165,874 Reduced 31.6%
359,126 $33.1 Million
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $3.57 Million - $5.03 Million
76,196 Added 16.98%
525,000 $26.4 Million
Q1 2023

May 15, 2023

BUY
$37.97 - $50.0 $2.99 Million - $3.94 Million
78,804 Added 21.3%
448,804 $20.2 Million
Q4 2022

Feb 14, 2023

BUY
$41.06 - $66.48 $2.19 Million - $3.55 Million
53,326 Added 16.84%
370,000 $16.2 Million
Q2 2022

Aug 15, 2022

BUY
$45.23 - $70.15 $4.03 Million - $6.25 Million
89,148 Added 39.18%
316,674 $16 Million
Q1 2022

May 16, 2022

BUY
$54.1 - $110.08 $1.65 Million - $3.36 Million
30,526 Added 15.5%
227,526 $14.5 Million
Q4 2020

Feb 16, 2021

SELL
$92.08 - $124.48 $3.5 Million - $4.73 Million
-37,979 Reduced 16.16%
197,000 $22.1 Million
Q3 2020

Nov 16, 2020

SELL
$66.45 - $92.7 $1.45 Million - $2.02 Million
-21,788 Reduced 8.49%
234,979 $21.8 Million
Q2 2020

Aug 14, 2020

BUY
$57.09 - $79.27 $1.28 Million - $1.78 Million
22,500 Added 9.6%
256,767 $20 Million
Q1 2020

May 15, 2020

BUY
$48.11 - $82.22 $3.06 Million - $5.23 Million
63,600 Added 37.27%
234,267 $13.7 Million
Q3 2019

Nov 14, 2019

BUY
$72.9 - $101.41 $2.75 Million - $3.82 Million
37,691 Added 28.34%
170,667 $12.5 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $4.81 Million - $6.4 Million
65,409 Added 96.81%
132,976 $12.5 Million
Q1 2019

May 15, 2019

BUY
$48.7 - $86.6 $3.29 Million - $5.85 Million
67,567 New
67,567 $5.41 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.44B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.